Silvia Morbelli is an associate professor at the University of Genoa. She earned her Ph.D. in applied neurosciences at the University of Genoa. From January to July 2004, she was an honorary clinical fellow of the Stroke Research Group, a University of Cambridge group. She worked as a referent nuclear medicine physician of the disease management team on cognitive disorders and dementia (CDCD) at the Polyclinic San Martino Hospital, Genoa, from 2019 to date. She is a member of the Italian Association of Nuclear Medicine (AIMN) and the European Association of Nuclear Medicine (EANM). Her main clinical and research activities include neuroimaging in neurodegenerative disorders: dementia and Parkinsonian syndromes; brain perfusion and DAT SPECT, FDG-PET, amyloid PET, 18F-DOPA; the use of biomarkers to support an early diagnosis and for the prognostic stratification of neurodegenerative dementia; and the cognitive reserve in neurodegenerative dementia. She also has clinical experience in whole body PET and radiometabolic therapy.